Dow Down0.17% Nasdaq Down0.28%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.26 Down 0.26(5.75%) Sep 30, 4:00PM EDT
|After Hours : 4.32 Up 0.06 (1.41%) Sep 30, 7:45PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 857   857   857   857  
Cost of Revenue -   -   -   -  
Gross Profit 857   857   857   857  
Operating Expenses
Research Development16,726  17,001  15,472  13,027  
Selling General and Administrative6,933  7,010  6,341  6,411  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (22,802) (23,154) (20,956) (18,581)
Income from Continuing Operations
Total Other Income/Expenses Net26  26  8  9  
Earnings Before Interest And Taxes(22,776)(23,128)(20,948)(18,572)
Interest Expense1,731  1,770  537   -  
Income Before Tax(24,507)(24,898)(21,485)(18,572)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(24,507)(24,898)(21,485)(18,572)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (24,507) (24,898) (21,485) (18,572)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (24,507) (24,898) (21,485) (18,572)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.